SABBY MANAGEMENT LLC 13D and 13G filings for InMed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-03 4:17 pm Purchase | 2024-12-31 | 13G | InMed Pharmaceuticals Inc. INM | SABBY MANAGEMENT LLC | 36,135 4.900% | 34,823 (+2653.29%) | Filing |
| 2024-01-03 5:43 pm Purchase | 2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM | SABBY MANAGEMENT LLC | 1,312 11.000% | 1,312 (New Position) | Filing |